<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04120064</url>
  </required_header>
  <id_info>
    <org_study_id>PIRB64</org_study_id>
    <nct_id>NCT04120064</nct_id>
  </id_info>
  <brief_title>Treatment of Vitamin D Deficiency With Large Bolus Cholecalciferol</brief_title>
  <official_title>Treatment of Vitamin D Deficiency With Large Bolus Cholecalciferol in the Outpatient Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parkview Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Parkview Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing two treatment regimens (solitary large dose vs daily smaller dose) in patients
      diagnosed with vitamin D deficiency.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study is looking at patients with diagnosed vitamin D deficiency (&lt;20ng/mL). Participants are
      healthy adults between 18 and 75. No diagnosis of cancer, pregnancy, hypercalcemia,
      hyperparathyroidism, gastrointestinal absorption disorder, or chronic kidney disease and not
      taking medications for seizures or osteoporosis. Participants are randomized into two
      treatment groups: (1) 5,000IU cholecalciferol daily or (2) one-time 300,000 international
      units (IU) cholecalciferol. Vitamin D level, calcium level, and renal function are measure
      one week after initiating treatment and then at 3 months, 6 months, 9 months, and 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2019</start_date>
  <completion_date type="Anticipated">May 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of treatment of vitamin D deficiency over a one year time frame: normalization of vitamin D levels above 30ng/mL</measure>
    <time_frame>12months</time_frame>
    <description>Looking for normalization of vitamin D levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of efficacy after starting vitamin D replacement as monitored at one week and then three month intervals for one year</measure>
    <time_frame>1 week, 3 months, 6 months, 9 months, 12 months</time_frame>
    <description>Evaluation of how long participants maintain normal vitamin D levels with treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with therapy as measured by the reported number of missed doses at one week on therapy and then every three months for a year</measure>
    <time_frame>1 week, 3 months, 6 months, 9 months, 12 months</time_frame>
    <description>Evaluation of missed doses</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Large bolus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>Large, one time dose of 300,000 IU oral cholecalciferol or daily 5,000 IU oral cholecalciferol</description>
    <arm_group_label>Large bolus</arm_group_label>
    <arm_group_label>Standard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-75yrs old

          -  serum 25(OH)-vitamin D level &lt;20ng/mL

          -  patient of Parkview Adult Medicine clinic

          -  not currently on cholecalciferol &gt;2,000IU daily

          -  no ergocalciferol administration within last week

        Exclusion Criteria:

          -  history of hypercalcemia or hyperparathyroidism

          -  history of chronic kidney disease with baseline creatinine &gt;1.1

          -  history of gastric absorption abnormalities

          -  history of Paget's disease or osteomalacia

          -  history of thyrotoxicosis

          -  known malignancy

          -  currently pregnant

          -  taking medications for osteoporosis or seizures

          -  taking more than 1200mg/day of calcium

          -  inpatient hospitalization at the initiation of study meds
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie Murphy, DO</last_name>
    <role>Study Chair</role>
    <affiliation>Parkview Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephanie Franquemont, DO</last_name>
    <phone>7195957585</phone>
    <email>Stephanie_franquemont@parkviewmc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Parkview Medical Center</name>
      <address>
        <city>Pueblo</city>
        <state>Colorado</state>
        <zip>81003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Franquemont, DO</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 6, 2019</study_first_submitted>
  <study_first_submitted_qc>October 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2019</study_first_posted>
  <last_update_submitted>October 17, 2019</last_update_submitted>
  <last_update_submitted_qc>October 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Parkview Medical Center</investigator_affiliation>
    <investigator_full_name>Stephanie Franquemont</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 23, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04120064/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 23, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04120064/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

